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In rat lacrimal glands, Forskolin induces a dose-dependent [3H]protein release. This effect can be 
potentiated by papaverine. As for the other inducers whose effects on protein secretion are assumed to 
be CAMP-mediated, Forskolin secretion time course shows a latency. Isoproterenol decreases the Forskolin 
EC50 at least 60-times. On the other hand, Forskolin enhances the efficacy of isoproterenol without 
affecting its potency. As a whole, the data collected show that isoproterenol-induced [3H]protein secretion 
in rat lacrimal glands involved adenylate cyclase activation by coupling with P-adrenergic receptors. 
Forskolin &Adrenergic receptor 
1. INTRODUCTION 
Some studies have shown the possibility of in- 
ducing a large peroxidase [1] or labeled protein [2] 
secretion via ,B-adrenergic receptors in rat lacrimal 
glands. In our laboratory, we found that this 
stimulation was accompanied by an increase in 
tissue CAMP content (submitted). On the other 
hand, authors in [3] failed to elicit a labeled pro- 
tein secretion through a P-adrenergic receptor ac- 
tivation. However, the same authors have describ- 
ed the possibility of promoting a significant label- 
ed protein discharge via ACTH and/or cu-MSH 
receptors coupled with an adenylate cyclase activi- 
ty [41. 
Forskolin, a diterpene, was shown to directly 
and specifically activate the adenylate cyclase in 
membrane preparations as well as in intact cells 
from various tissues [5,6]. Up to now, only a few 
Abbreviations: PGE,, PGEz, PGDz and PGIz, pro- L-[3H]Leucine was purchased from the C.E.A. 
staglandin El, Ez, D2, 12; CAMP, 3’ ,5’-adenosine Saclay, France. L-Isoproterenol bitartrate and 
monophosphate; ACTH, adrenocorticotropic hormone; papaverine hydrochloride were from Sigma, St 
wMSH, cu-melanocyte-stimulating hormone; VIP, Louis. Atropine sulfate was purchased from 
vasoactive intestinal peptide; TSH, thyroid-stimulating Calbiochem (Los Angeles CA), I-propranolol from 
hormone ICI Pharmacia (Enghien) and phentolamine 
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of these studies have been performed on 
physiological processes dependent (or postulated 
to be) on an intracellular CAMP level increase due 
to an adenylate cyclase activation [7-91. 
Recently, it has been reported that Forskolin ac- 
tivates the fluid secretion in blowfly salivary glands 
[lo]. Thus, Forskolin appears to be a useful tool to 
investigate whether isoproterenol induced labeled 
protein secretion, in rat lacrimal glands, is elicited 
by a mechanism involving a coupling between ,8- 
adrenergic receptors and adenylate cyclase activity. 
This work shows that Forskolin evokes a labeled 
protein secretion and that it enhances the 
isoproterenol stimulation by increasing the ef- 
ficacy of ,&-adrenergic agonist without affecting its 
potency. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
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sulfonate from Ciba Geigy Laboratories (Lyon). 
Forskolin was a kind gift from Hoechst France and 
was made up as a 10 mM stock solution in 75% 
ethanol (v/v). 
2.2. Biological material 
Fragments of lacrimal glands from male albino 
Sprague-Dawley rats (6-8 weeks old) were 
prepared as in [ 111. 
2.3. Incubation procedures 
2.3.1. ‘Fixed time’ discharge experiments 
Incubation procedure, pulse labeling (10 min) 
and protein discharge were performed as in 
[11,12]. The protein pellet was dissolved in 0.5 N 
NaOH and the radioactivity was determined using 
aqualuma as scintillation cocktail on Packard Tri- 
Carb Scintillation Counter. 
Results were expressed either directly as the 
amount of labeled proteins present in the incuba- 
tion medium, as a percentage of total labeled pro- 
teins in tissue and medium, or by the stimulation 
factor which is the ratio of the % of protein 
secreted under stimulation to the % of protein 
secreted in the unstimulated state at the same time. 
2.3.2. Time course of protein secretion 
Incubation procedure and pulse labeling were as 
above, but protein discharge was determined on a 
duplicate aliquot (0.5 ml) of the incubation 
medium for each time indicated in legends. The 
protein radioactivity of both tissue and medium 
was determined as above. The results were express- 
ed as cumulative protein secretion v.s time. 
All [3H]protein discharges were performed in the 
presence of the same amount of ethanol (0.75% 
final concentration) to avoid a possible effect of 
the Forskolin solvent on the secretory process. 
Each experiment was performed 3-times and each 
result reported is a representative one. 
3. RESULTS 
The effects of Forskolin on protein secretion in 
rat lacrimal glands pieces are shown in fig.1. For- 
skolin alone induced a concentration-dependent 
release of labeled proteins; this effect could be 
potentiated by 10 PM papaverine, a CAMP 
phosphodiesterase inhibitor (fig. 1A). The For- 
skolin stimulation was not affected by the an- 
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Fig.1. Effect of papaverine and isoproterenol on 
Forskolin-induced protein secretion. 13H]protein 
discharge was performed in the presence of various 
concentrations of Forskolin for 40 min. (A) Incubations 
were performed in the absence (m) or in the 
presence (ti) of 10pM papaverine added 10 min 
before Forskolin; (B) Incubations in the absence 
(0-O) or in the presence (H) of 5 pM 
isoproterenol added along with Forskolin. Dashed line 
indicates the theoretical sum of the two individual 
responses for each Forskolin concentration. 
tagonists of muscarinic or adrenergic receptors 
(atropine, phentolamine or 1-propranolol; not 
shown). Fig. 1B shows the effect of isoproterenol (a 
specific P-adrenergic agonist) on labeled protein 
secretion induced by increasing concentrations of 
Forskolin. Since the dose-response curve for For- 
skolin alone failed to reach any plateau in the con- 
centration range tested, half the maximal effect 
(ECso) can only be estimated to be higher than 
30pM Forskolin. Isoproterenol at 5 PM shifted 
this EC50 to about 0.5 PM. At 10 PM Forskolin, 
isoproterenol substantially increases protein secre- 
tion, but at 100 PM, it was almost the same as the 
theoretical sum of the two individual responses 
(Forskolin or isoproterenol alone). The effect of 
3 PM Forskolin which elicited only a partial 
stimulation of protein secretion was tested on the 
secretory response due to increasing concentra- 
tions of isoproterenol. The data in fig.2 show that, 
while this limited concentration of Forskolin did 
not significantly affect the E&,-value for 
isoproterenol, it increased its maximal response to 
a level higher than the sum of the two individual 
responses. 
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Fig.2. Effect of Forskolin on isoproterenol-induced 
protein secretion. (3H]protein secretion was performed 
in the presence of various concentrations of 
isoproterenol both in the absence (M) or in the 
presence (M) of 3 pM Forskolin. Dashed line 
indicates the theoretical sum of the two individual 
responses for each isoproterenol concentration. 
The time course of labeled protein secretion 
under 10 FM Forskolin stimulation in the presence 
or absence of papaverine, as shown in fig.3, 
demonstrates the existence of a lag time period. In 
both cases the linearity of the protein secretion was 
obtained 20 min after Forskolin was added to the 
incubation medium. Papaverine, which has no ef- 
fect by itself, promotes a 2-fold stimulation of the 
net secretion rate induced by Forskolin. 
4. DISCUSSION 
Here we used Forskolin, a potent activator of 
adenylate cyclase in order to have an indirect proof 
of CAMP involvement in the regulation of the ex- 
ocrine secretory process in rat lacrimal glands, 
mainly through the coupling ,&-adrenergic 
receptor-adenylate cyclase. It was shown that For- 
skolin alone was able to elicit a significant protein 
secretion as soon as 1 PM (fig. IA), a concentration 
which provokes a 50% maximal increase in CAMP 
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Fig.3. Time course of protein secretion elicited by 
Forskolin. Time course of protein secretion was 
performed as indicated in section 2. Incubations were 
conducted in the absence (M) or in the presence 
(&--A) of 10 pM papaverine added 10 min before 
10 PM Forskolin. (o--+) indicates unstimulated 
protein secretion both in the absence or presence of 
papaverine. 
accumulation in blowfly salivary glands as in [lo]. 
Moreover, as could be postulated for a CAMP- 
dependent mechanism, an agent which inhibits the 
CAMP degradation (papaverine) increases the 
secretory response for all the Forskolin concentra- 
tions tested. A similar result was obtained for 
CAMP accumulation in rat brain slices [I 31 with 
ZK 62771 as phosphodiesterase inhibitor. It is 
noteworthy that the protein discharge induced by 
Forskolin cannot be due to receptor activation or 
result from neurotransmitter elease from nerve 
endings since none of the antagonists of the 
muscarinic, w and P-adrenergic receptors present 
in the lacrimal gland was able to inhibit the 
secretory response to the diterpene. 
The effect of isoproterenol on the response to in- 
creasing concentrations of Forskolin, i.e., the shift 
in the EC’s0 concentration of Forskolin (from more 
than 30pM to 0.5 PM), is analogous to the results 
reported with PGEI on Forskolin stimulation of 
adenylate cyclase activity in membrane prepara- 
23 
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tions [14] or with PGEi, PGD?, PGIz, 
isoproterenol and TSH on CAMP accumulation in 
intact cells [7,8,15]. 
The isoproterenol-induced stimulation of pro- 
tein discharge is potentiated by low concentration 
of Forskolin since the maximal secretory response 
in the presence of both products is higher than the 
sum of the response for the products alone. The ef- 
ficacy of isoproterenol is increased but its EC50 
does not seem to be shifted by the diterpene. This 
result agrees with those obtained with the stimula- 
tion of CAMP accumulation by histamine in 
guinea-pig brain slices, norepinephrine in rat brain 
slices [6] and TSH in bovine thyroid glands. 
However, our result is different from those where 
Forskolin increased only the potency of the 
agonists, VIP and PGE2 [6], or where it increased 
both the efficacy and the potency of the agonists 
PGEi, PGDz and PGI2 [7]. Moreover, our data 
can also be compared to those reported for other 
physiological processes: the effect of Forskolin on 
steroidogenesis nduced by ACTH [9], on lipolysis 
induced by isoproterenol [8] and on the inhibition 
of platelet aggregation induced by PGEi [7]. 
The absence of labeled protein detected in the in- 
cubation medium above that of the control for 
10 min after Forskolin has been added, was in 
agreement with the latency in the time course of 
peroxidase [I] or labeled protein secretion (submit- 
ted) elicited in the same tissue by inducers whose 
effects are assumed to be CAMP-mediated: 
isoproterenol, db-CAMP or methylxanthines. On 
the other hand, the authors in [3,4] did not report 
a latency concerning the labeled protein discharge 
induced in rat lacrimal glands by ACTH nor by cy- 
MSH, even though they show that these responses 
are CAMP-mediated. This discrepancy between the 
ACTH or (r-MSH responses and the others also 
postulated to CAMP-mediated has not been 
elucidated. 
The results obtained with Forskolin on the 
stimulation of the t3H]protein discharge in rat 
lacrimal glands are well correlated to those 
reported for the adenylate cyclase activity or 
CAMP accumulation increased by this diterpene in 
other tissues. 
As opposed to the results in [3,4], the data 
reported here suggest hat labeled protein secretion 
can be triggered off in rat lacrimal glands through 
24 
a mechanism involving a CAMP intracellular level 
increase (submitted) due to adenylate cyclase ac- 
tivation by coupling this enzyme with ,&-adrenergic 
receptors. 
Furthermore, Forskolin appears to be a very 
useful tool in defining the role of adenylate cyclase 
activity in the hormonal or neurotransmitter 
regulation of protein secretion in exocrine glands. 
ACKNOWLEDGEMENTS 
Thanks are due to J. Dujancourt for her skilful 
technical assistance. This work was supported by 
the Centre National de la Recherche Scientifique 
(LA 272, ATP: Pharmacologic des recepteurs des 
neuromediateurs) and Laboratories Hoechst. 
REFERENCES 
111 
PI 
131 
[41 
151 
161 
[71 
VI 
191 
[lOI 
1111 
WI 
t131 
(141 
Friedman, Z.Y., Lowe, M. and Zeliger, Z. (1981) 
Biochim. Biophys. Acta 675, 40-45. 
Mauduit, P., Herman, G. and Rossignol, B. (1982) 
Biol. Cell 45, 281. 
Jahn, R. and Saling, H.D. (1981) FEBS Lett. 131, 
28-30. 
Jahn, R., Padel, U., Porsch, P.H. and Soling, 
H.D. (1982) Eur. J. Biochem. 126, 623-629. 
Seamon, K.B., Padgett, W. and Daly, J.W. (1981) 
Proc. Natl. Acad. Sci. USA 78, 3363-3367. 
Seamon, K.B. and Daly, J.W. (1981) J. Cyclic 
Nucleotide Res. 7, 201-224. 
Siegl, A.M., Daly, J.W. and Smith, J.B. (1982) 
Mol. Pharmacol. 21, 680-687. 
Litosh, I., Hudson, T.H., Mills, I., Shih-Ying Li 
and Fain, J.N. (1982) Mol. Pharmacol. 22, 
109-115. 
Moriwaki, K., Itoh, Y., Iida, S. and Ichihara, K. 
(1982) Life Sci. 30, 2235-2240. 
Litosh, I., Saito, Y. and Fain, J.N. (1981) 
Biochem. J. 204, 147-151. 
Chambaut-Guerin, A.M., Muller, P. and 
Rossignol, B. (1978) J. Biol. Chem. 253, 
3870-3876. 
Rossignol, B., Herman, G. and Clauser, H. (1969) 
Biochem. Biophys. Res. Commun. 34, 111-119. 
Daly, J.W., Padgett, W. and Seamon, K.B. (1982) 
J. Neurochem. 38, 532-544. 
Insel, P.A., Stenge, D., Ferry, N. and Hanoune, J. 
(1982) J. Biol. Chem. 257, 7485-7490. 
1151 Fradkin, J.E., Cook, G.H., Hilhoffer, M.C. and 
Wolff, J. (1982) Endocrinology 111, 849-856. 
